Quoin Pharmaceuticals Advances QRX003 for Netherton Syndrome
Ashburn, Virginia — March 9, 2026 Clinical-stage specialty biopharmaceutical company Quoin Pharmaceuticals Ltd. continues to advance the development of...
Biotechnology Innovation
Advertisement
Capricor Unveils Scalable Exosome Platform for Oligonucleotide Delivery
San Diego, California, November 24, 2025 — Capricor Therapeutics, Inc. announced new data at the AAEV 2025 meeting that...
Wave Life Sciences Advances RNA Innovation Ahead of Q3 2025 Results
CAMBRIDGE, Mass., November 4, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company pioneering the use...
Kodiak’s KSI-101 Delivers Promising Data in Retinal Disease Study
PALO ALTO, Calif., Sept. 15, 2025 – Kodiak Sciences Inc. (Nasdaq: KOD), a retina-focused biotechnology company, announced new data...
Advertisement
